Strategic Capital Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Strategic Capital Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-915	Closed	-$259K	–	54
2020 Q1	$259K	Sell	915 -134	-13%	-$42.3K	0.31%	45
2019 Q4	$341K	Hold	1,049	–	–	0.32%	47
2019 Q3	$305K	Sell	1,049 -75	-7%	-$21.5K	0.34%	49
2019 Q2	$330K	Hold	1,124	–	–	0.35%	47
2019 Q1	$308K	Buy	+1,124	New	+$280K	0.33%	46
2018 Q4	–	Sell	-873	Closed	-$213K	–	61
2018 Q3	$213K	Hold	873	–	–	0.15%	56
2018 Q2	$205K	Buy	+873	New	+$185K	0.15%	58

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Strategic Capital Advisers's TMO Position: Q2 2020 in Review

Strategic Capital Advisers sold out of Thermo Fisher Scientific (TMO) in Q2 2020, closing a stake of 915 shares — an estimated $259K sold.

Strategic Capital Advisers first reported a position in TMO in Q2 2018 and held it in 7 quarters. The position peaked at $341K in Q4 2019. 1,748 funds tracked by Wall St. Rank hold TMO as of Q2 2020.

Strategic Capital Advisers reported no remaining Thermo Fisher Scientific position as of Q2 2020 after selling out during the quarter.
Strategic Capital Advisers sold 915 Thermo Fisher Scientific shares in Q2 2020, an estimated $259K.
Strategic Capital Advisers first reported a position in Thermo Fisher Scientific in Q2 2018 and held it in 7 quarters.
Strategic Capital Advisers's Thermo Fisher Scientific position peaked at $341K in Q4 2019.
1,748 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2020.

Based on Strategic Capital Advisers's 13F filing for Q2 2020, filed 6 Aug 2020.